Drug Safety in Developing Countries - 1st Edition - ISBN: 9780128198377

Drug Safety in Developing Countries

1st Edition

Achievements and Challenges

0.0 star rating Write a review
Editors: Yaser Al-Worafi
Paperback ISBN: 9780128198377
Imprint: Academic Press
Published Date: 4th June 2020
Page Count: 320
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries.

Key Features

  • Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues
  • Describes current achievements of drug safety practice in developing countries
  • Addresses the challenges of drug safety in developing countries
  • Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety


Researchers and advanced students in biomedical sciences, cell biology, physiology, pathology and pharmacology. Clinicians and pathologists interested in tissue barrier diseases

Table of Contents

1. Introduction: Why do we need a book on Drug Safety in developing countries?

Section 1: Drug safety related issues
2. Medications safety related terminology
3. Medications registration and marketing: Safety related issues
4. Pharmacovigilance
5. Adverse Drug Reactions
6. Medication errors
7. Self-medications
8. Antibiotics safety issues
9. Drug related problems (DRPs)
10. Counterfeit and substandard medications
11. Medications abuse and misuse
12. Storage and disposal of medications
13. Safety of medications in special populations
14. Herbal medicines safety issues
15. Medications safety resources and tools
16. Medications safety Pharmacoeconomics related issues
17. Evidence-Based Medication Safety Practice
18. Technology in Medications safety
19. Medications safety research issues 
20. Quality Indicators for medications safety

Section 2: Drug Safety in Asia
21. Drug safety in Malaysia
22. Drug safety in Thailand
23. Drug safety in Indonesia
24. Drug safety in Pakistan
25. Drug safety in India
26. Drug safety in Nepal
27. Drug safety in Sri Lanka
28. Drug Safety in China

Section 3: Drug Safety in Middle East
29. Drug safety in Yemen
30. Drug safety in Saudi Arabia
31. Drug safety in UAE
32. Drug safety in Jordan
33. Drug safety in Lebanon
34. Drug safety in Palestine
35. Drug safety in Qatar

Section 4: Drug Safety in Africa
36. Drug safety in Sudan
37. Drug safety in Egypt
38. Drug safety in Nigeria
39. Drug safety in Mali
40. Drug safety in Burkina Faso

Section 5: Drug Safety in Latin America
41. Drug safety in Chile

Section 6: Comparisons and conclusions
42. Compare between the developing countries
43. Drug Safety in Developing Versus Developed countries


No. of pages:
© Academic Press 2020
4th June 2020
Academic Press
Paperback ISBN:

About the Editor

Yaser Al-Worafi

Dr. Yaser Mohammed Al-Worafi is a Professor of Clinical Pharmacy at College of Pharmacy, Ajman University, UAE & UST-Yemen. He graduated with a bachelor's degree in Pharmacy (BPharm) from Sana’a University, Yemen and obtained Master and PhD degree in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. He has more than 15 years’ experience in education, practice and research in Yemen, Saudi Arabia, United Arab Emirates and Malaysia. He has held various academic and professional positions including: Head of pharmacy Practice department; Teaching & learning committee, Training committee and other committees. He has published over 40 peer-reviewed papers in international journals, book chapters and editing many books. He is a reviewer for eight recognized International peer-reviewed journals. Dr. Al-Worafi prepared and wrote the first draft of Master of Clinical pharmacy program and PharmD internship manual.

Affiliations and Expertise

Professor of Clinical Pharmacy, College of Pharmacy, University of Science and Technology, Yemen; University of Science and Technology of Fujairah, UAE

Ratings and Reviews